Cystic Fibrosis News Today Weekly Digest

Cystic Fibrosis Weekly Update Contents: Gene Editing In Utero May Prevent Fatal Lung Diseases After Birth, Mouse Study Suggests AmorChem, UdeS Team Up to Advance Research of Natural Antibiotic Against Infections Linked to CF Gene Editing In Utero May Prevent Fatal Lung Diseases After Birth, Mouse Study Suggests Apr 24, 2019 07:00 am | Patricia Inacio, PhD Using the gene editing tool CRISPR-Cas9 to specifically target the lung of a developing fetus, researchers were able to correct a mutation associated with a human lung disease that is fatal after birth, a study in mice shows. These findings highlight the potential of gene editing strategies to correct mutations associated with genetic lung diseases, including […] The post Gene Editing In Utero May Prevent Fatal Lung Diseases After Birth, Mouse Study Suggests appeared first on Cystic Fibrosis News Today. Read More AmorChem, UdeS Team Up to Advance Research of Natural Antibiotic Against Infections Linked to CF Apr 23, 2019 07:00 am | Santiago Gisler The early-stage venture capital fund AmorChem has entered an agreement with Université de Sherbrooke (UdeS) and TransferTech Sherbrooke, in Canada, to optimize the antibiotic tomatidine for treating infections associated with cystic fibrosis (CF). Tomatidine is a naturally occurring product that can be extracted from tomatoes. Previous findings have shown that tomatidine and analogous (comparable) molecules have antibiotic […] The post AmorChem, UdeS Team Up to Advance Research of Natural Antibiotic Against Infections Linked to CF appeared first on Cystic Fibrosis News Today. Read More   Recent News We Must Pay Closer Attention to the Global CF Population AbbVie Opens Scholarship Applications for Students with Cystic Fibrosis Can We Take a Minute to Rest? New Test Could Lead to Effectively Customizing Treatments for CF Patients, Study Contends How I’ve Found Purpose Without Having a Full-time Job